Eisai Co., Ltd. (TYO:4523)
4,180.00
-2.00 (-0.05%)
Jul 25, 2025, 3:30 PM JST
Eisai Employees
Eisai had 10,917 employees as of March 31, 2025. The number of employees decreased by 150 or -1.36% compared to the previous year.
Employees
10,917
Change (1Y)
-150
Growth (1Y)
-1.36%
Revenue / Employee
72.31M JPY
Profits / Employee
4.25M JPY
Market Cap
1,178.29B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Chugai Pharmaceutical | 5,026 |
Takeda Pharmaceutical Company | 47,455 |
Daiichi Sankyo Company | 19,765 |
HOYA Corporation | 37,909 |
Otsuka Holdings | 35,338 |
Astellas Pharma | 13,643 |
Shionogi & | 4,955 |
Olympus | 29,297 |
Eisai News
- 11 days ago - "URECE" (Dotinurad) Launched in China as a treatment for Gout - Benzinga
- 6 weeks ago - Eisai: Leqembi Approved In EU (Rating Downgrade) - Seeking Alpha
- 2 months ago - Eisai Co., Ltd. (ESALF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Eisai Co., Ltd. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 2 months ago - Eisai GAAP EPS of ¥163.76, revenue of ¥789.4B; initiates FY outlook - Seeking Alpha
- 3 months ago - Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion - Benzinga
- 3 months ago - Biogen/ Eisai win EU approval for Alzheimer’s therapy - Seeking Alpha
- 3 months ago - EU authorizes Eisai-Biogen's drug for treatment of early Alzheimer's disease - Reuters